Is Adial Pharmaceuticals, Inc. (ADIL) a Buy, Sell, or Hold?
NASDAQ : ADIL
Adial Pharmaceuticals, Inc. — News
$3.34 USD
$0.05 (1.52%)
- Volume
- 51.33K
- Average Volume
- 460.17K
- Market Capitalization
- $3.21M
- P/E Ratio
- -0.34
- Dividend Yield
- 0.00%
- Price Target
- $7.00
- Year High
- $11.50
- Year Low
- $1.31
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.18
| Source | Headline |
|---|---|
|
Adial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing
GLEN ALLEN, Va., June 16, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that the Company's Compensation Committee and Board of Directors granted Matthew Davidson and Julie Saiki, the Company's newly appointed chief development officer and executive vice president of strategy, respectively, restricted stock units and stock options to purchase Company common stock as an inducement to them becoming employees of the Company in connection with the closing of its business combination with Azora Therapeutics, Inc. (“Azora”), which was previously announced by the Company on June 11, 2026. globenewswire.com - 2026-06-16 08:00:00 |
|
Adial Pharmaceuticals Announces Acquisition of Azora Therapeutics and up to $64 Million Financing
- Acquisition of Azora and concurrent private placement positions the combined company to advance its pipeline through key clinical milestones in ulcerative colitis, including Phase 1 initiation in mid-2027 globenewswire.com - 2026-06-11 11:43:00 |
|
Adial Pharmaceuticals Reports 2026 First Quarter Financial Results and Provides Business Update
GLEN ALLEN, Va., May 11, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today provided a business update and reported its financial results for the 2026 first quarter ended March 31, 2026. globenewswire.com - 2026-05-11 08:30:00 |
